UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000023553 |
|---|---|
| Receipt number | R000026760 |
| Scientific Title | The multicenter clinical test which considers predictive risk factors of acute kidney injury after chemotherapy including cisplatinun |
| Date of disclosure of the study information | 2016/10/01 |
| Last modified on | 2016/07/18 11:22:39 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The multicenter clinical test which considers predictive risk factors of acute kidney injury after chemotherapy including cisplatinun
Acronym
predictive risk factors of AKI after chemotherapy including CDPP
Scientific Title
The multicenter clinical test which considers predictive risk factors of acute kidney injury after chemotherapy including cisplatinun
Scientific Title:Acronym
predictive risk factors of AKI after chemotherapy including CDPP
Region
| Japan |
Condition
Condition
Urothelial cancer
Classification by specialty
| Urology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
We evaluated the predictive risk factors of AKI after chemotherapy including CDDP
Basic objectives2
Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
the presence or absence of AKI after CDDP chemotherapy
Key secondary outcomes
the predictive risk factors of AKI after chemotherapy including CDDP
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | < |
Age-upper limit
| 85 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
patients with urothelial cancer with chemotherapy including CDDP
first-pearson informed consent
Key exclusion criteria
patient with maintenance HD therapy
Target sample size
50
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | SATORU MUTO |
Organization
Teikyo University School of Medicine
Division name
Department of Urology
Zip code
Address
2-11-1, Kaga, Itabashi-ku, Tokyo, Japan
TEL
0339641211
urology@med.teikyo-u.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | SATORU MUTO |
Organization
Teikyo Universith School of Medicine
Division name
Department of Urology
Zip code
Address
2-11-1, Kaga, Itabashi-ku, Tokyo, Japan
TEL
0339641211
Homepage URL
urology@med.teikyo-u.ac.jp
Sponsor or person
Institute
Teikyo Universith School of Medicine
Institute
Department
Personal name
Funding Source
Organization
Teikyo Universith School of Medicine
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2016 | Year | 10 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2016 | Year | 10 | Month | 01 | Day |
Date of IRB
Anticipated trial start date
| 2016 | Year | 10 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
none
Management information
Registered date
| 2016 | Year | 08 | Month | 09 | Day |
Last modified on
| 2016 | Year | 07 | Month | 18 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026760
